Furthermore, interactions between BCCs and osteoblasts via ERK1/2 activation mediate the phenotypic switching of osteoblasts from an anabolic to catabolic state, which is required for BCC proliferation and destruction of bone. This evidence concerns the gene MAPK3 and skin basal cell carcinoma.